Navigation Links
Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO
Date:6/16/2008

PASADENA, Calif., June 16 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today will shuttle more than 100 life science executives from around the world on a tour of Green and LEED certified buildings and environmentally sustainable operations in the San Diego life science cluster market. This unique BIO Bus Tour is being held in conjunction with the Biotechnology Industry Organization's International 2008 Convention taking place in San Diego, California.

Alexandria has a dominant market position in its San Diego life science cluster market. It currently owns and operates approximately 2.2 million square feet of office/laboratory space in that market, including approximately 440,000 square feet of embedded future ground up development. San Diego is home to leading pharmaceutical, biotechnology, life science product and service companies, as well as renowned scientific research institutions. Alexandria has strongly supported and assisted the growth of the life science industry in San Diego. Alexandria includes amongst its prestigious client tenants in San Diego: Amylin Pharmaceuticals, Inc., The Scripps Research Institute, Syngenta AG, Laboratory Corporation of America, Senomyx, Inc., Biogen Idec, Arena Pharmaceuticals, Inc., Smith & Nephew plc, Ambrx, Inc., Genzyme Corporation, Forward Ventures and Becton, Dickinson and Company.

The tour will be conducted at the premises of several Alexandria client tenants: the amenities building of Amylin Pharmaceuticals, Inc. located at 4575 Eastgate Mall, which has received LEED Certification, and The Burnham Institute for Medical Research, located at 3010 Science Park Road for which LEED status is being pursued. The tour will also include visits to University of California San Diego, the Salk Institute for Biological Studies, The Scripps Research Institute, Genomics Institute of the Novartis Research Foundation and the headquarters of Biogen Idec. The facilities featured on the tour will highlight conservation efforts at various life science institutions and will also demonstrate how operations at office/laboratory buildings have been improved in order to become energy efficient and environmentally sustainable.

"As the pioneer at the vanguard of the sustainability initiative in our office/ laboratory niche, Alexandria continues to build on its world class expertise and experience in its life science cluster strategy, leading the way toward implementing sustainable materials and operational performance with green technologies in the laboratory environment," said Joel S. Marcus, Chief Executive Officer of Alexandria. "We are proud to have been the first company in California to have a Core and Shell laboratory project to be LEED Silver certified and we continue to innovate with the design and construction of state-of-the-art office/laboratory spaces that meet the needs of the industry. There is also great interest in net zero energy consumption which Alexandria is heavily focused on as well."

Alexandria's high performance green buildings are equipped with high efficiency chillers and boilers, non-chemical water treatment systems and recycled materials. The buildings utilize day lighting, spectrally selective glazing, motion sensors and dimming controls. These efficiencies reduce HVAC (heating, ventilating and air conditioning) electricity consumption and decrease water use.

Mr. Marcus continued, "We have proven that life science entities do not have to sacrifice functionality in order to be environmentally efficient. In fact, our leading green initiatives help lower tenant costs and operating expenses while continuing to provide entities with a state-of-the-art work environment that fosters continued translation of leading edge science and breakthrough products which contribute significantly to better human health."

About LEED (Leadership in Energy and Environmental Design)

LEED is the nationally accepted benchmark for the design, construction and operation of high performance green buildings. LEED promotes a whole-building approach to sustainability by recognizing performance in five key areas of human and environmental health: sustainable site development, water savings, energy efficiency, materials selection and indoor environmental quality.

Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry(R), is the largest owner and preeminent first-in-class international real estate investment trust focused principally on science- driven cluster formation through the ownership, operation, management, redevelopment, selective development and acquisition of properties containing technical environments, including office/laboratory space. Alexandria is the leading provider of high-quality environmentally sustainable real estate, technical infrastructure, services and capital to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biotechnology, medical device, product, service, and translational entities, as well as government agencies. Alexandria's operating platform is based on the principle of "clustering," with assets and operations located in key life science markets. Our asset base approximates 13.3 million rentable square feet consisting of 159 properties approximating 11.7 million rentable square feet (including spaces undergoing active redevelopment) and properties undergoing ground-up development approximating 1.6 million rentable square feet. In addition, our asset base will enable us to grow to approximately 22.3 million square feet through future ground-up development approximating 9.0 million square feet of office/laboratory space.

This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
2. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
3. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
4. Unigene Restates Policy on Analyst Reports
5. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. Coherent Announces Restatement Related to Stock-Based Compensation
8. Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
9. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
10. National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welchs Foods
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature their new ... San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused BiOS Expo ... PIN diode standard packages feature a TO-46 metal can with active areas of 1.0mm ...
(Date:2/10/2016)... ... 10, 2016 , ... Global Stem Cells Group, ... Global Stem Cells Network (GSCN) and its affiliate Global Medical Training Network ... adipose and bone marrow therapies. , Through the new collaboration, Global Stem ...
(Date:2/9/2016)... Feb. 9, 2016  Regenicin, Inc. (OTC Bulletin ... in the development and commercialization of regenerative cell ... and organs, recently reported the Company,s operating results ... of 2016. Lonza America , Inc. ... fiscal year in the process of consummating an ...
(Date:2/9/2016)... PA (PRWEB) , ... February 09, 2016 , ... Tunnell ... Europe. Based in Paris, he will focus on acquiring new accounts and work ... met. , “Fred brings to our European clients more than 15 ...
Breaking Biology Technology:
(Date:1/25/2016)... 25, 2016   Unisys Corporation (NYSE: UIS ) ... Kennedy (JFK) International Airport, New York City , ... imposters attempting to enter the United States ... pilot testing of the system at Dulles last ... at JFK during January 2016. --> pilot testing ...
(Date:1/21/2016)... 2016 --> ... research report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, ... Expression, Voice Recognition and Others), Services, Application Areas, ... 2020", published by MarketsandMarkets, the global Emotion Detection ... 22.65 Billion by 2020, at a CAGR of ...
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
Breaking Biology News(10 mins):